Alignment Healthcare, Inc. Common StockALHC
Recorded

Alignment Healthcare, Inc. Common Stock 2026 Global Healthcare Conference

Review the key takeaways and the transcript of this earnings call.

Period 2026Duration31 minParticipants3

Transcript

Preview the first fifteen paragraphs, organized by speaker.

Michael HaAnalyst

Yeah. Okay, great. Thank you. Welcome, everyone. My name is Michael Ha, the managed care and healthcare facilities analyst at Baird. Our next session is with Alignment Health, a technology-enabled managed care company focused on the Medicare Advantage business. I am very pleased to have with us today Chief Executive Officer, John Kao, and Chief Financial Officer, Jim Head, as well as Head of IR, Harrison Zhou. Thank you all for being here. With that said, no intro comments. We will jump right into the Q&A.

John KaoCEO

Thanks for having us, Michael.

Michael HaAnalyst

Good morning, everybody. Great. A hot topic, you now have the final cut points and visibility into your measure level performance.

Michael HaAnalyst

Can you characterize how you feel about your overall positioning? Has your level of confidence changed at all since second quarter?

John KaoCEO

No. No. No, everybody, seriously, I think CMS this year is very sensitive about anybody commenting around the Plan Preview 2. I cannot talk about it at all from a regulatory point of view. You have heard me say in the past, I thought we were close. You have heard me say we were not happy about the HEI decisioning, particularly that that decision was after the actual implementation period. But other than that, I just cannot comment it. I think this year is different than prior years, and we do not want to be the one poking the bear.

Michael HaAnalyst

Got it. That's fair. I guess follow up on cut points to the extent you're able to comment. In previous years, you've been pretty aggressive, right? I guess this year, do they make more sense this year than prior years?

John KaoCEO

Nice try, Michael. I love you, but I honestly cannot even go there at all. I would acknowledge, in the past, we have been much more open. This year's different, and I think part of it is just all the scrutiny around Stars itself, all the policy discussions, all the legal discussions. Again, we don't want to be the ones that go there.

Michael HaAnalyst

Got it. Fair. I have to try.

John KaoCEO

Thank you. Just wait a couple of weeks, and we'll roll it all out when it comes out, whenever it's mid-October.

Michael HaAnalyst

Okay. Thank you. Okay, stepping back, Alignment delivered strong membership growth, revenue growth, EBITDA margin expansion in the second quarter, but the stock reaction suggests investors remain focused on things like second half cadence, the unfavorable development, investment spending, Stars.

Michael HaAnalyst

Yep. I was wondering if you would help frame what you believe investors may be overlooking and what upcoming, call it, milestones should provide greater confidence.

John KaoCEO

Yeah. No. I think after last quarter's call, the consistent question was, "Look, you guys have been so pristine over the past five years. You have always beaten raise. You have had a lot of consistency. You have set that expectation. What is different?" There seems to be noise now. That was the consistent discussion we got. Let me connect the dots for everybody. The other things we have said include, number one, the proof of concept of getting to 300,000 members, $5 billion, our clinical MLRs producing, has given us a lot of confidence. The proof of concept works. That is number one. Number two is we have also said we are scaling the company. What that really means to investors, you should understand it. It is doing a diagnostic on every part of our company when the company was doing really well.

John KaoCEO

We did not wait until the you know what hit the fan. We actually started looking at ourselves, making changes at every functional area of the company in order to make ourselves not just a big small company, but we needed to be a small big company. That required a lot of changes, aggressive change management agenda over the past couple of years. We looked at our claim systems. We looked at our medical management capabilities. We looked at our data architecture. We looked hard at AVA. We looked at all of these things, and we started making investments to change all of those, in order to also, point three, get to where we needed to get to, which we said we want to get to at least 1 million members.

John KaoCEO

As we did that, I looked at our core systems, our workflows, and we needed to make these investments. Anything that I think people are pointing to now is, in my mind, noise resulting from those change management initiatives. Okay? We are largely through a lot of it. Specifically, whenever you go through a claims application implementation, those are messy and noisy. We are pretty much through the end of that, and there is a lot of data points that would suggest that, all in terms of claims throughput, inventory, lag days, adjustments, all that noise is starting to settle down. I think there are other areas that are still yet to be fully complete. I think the last thing I would say that I have said is I really think there is a lot of low-hanging fruit, resulting from the diagnostic.

John KaoCEO

We have not picked up all that low-hanging fruit yet, but we will. In the next couple of quarters, we will get that done. That is the point. I would not confuse the integrity of the business model with the short-term noise resulting from a very, very aggressive change management agenda. We can talk about that in greater depth in the breakouts.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Access every statement, the English original, and speaker-by-speaker history with StockNow Pro.

View the full transcript with Pro

More recent earnings calls

View earnings calendar